The Enterprise Value as of December 2025 (TTM) for Egetis Therapeutics AB (publ) (EGTX.ST) is 1.61B

According to Egetis Therapeutics AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 1.61B. This represents a change of -7.21% compared to the average of 1.73B of the last 4 quarters.

Egetis Therapeutics AB (publ) (EGTX.ST) Historical Enterprise Value (quarterly & annually)

How has EGTX.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Egetis Therapeutics AB (publ) over the last ten years is 964.82M. The current 1.61B Enterprise Value has changed 16.58% with respect to the historical average. Over the past ten years (40 quarters), EGTX.ST's Enterprise Value was at its highest in in the December 2024 quarter at 2.20B. The Enterprise Value was at its lowest in in the June 2020 quarter at 108.19M.

Egetis Therapeutics AB (publ) (EGTX.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Egetis Therapeutics AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Egetis Therapeutics AB (publ) (EGTX.ST) Average Enterprise Value

How has EGTX.ST Enterprise Value performed in the past?

The current Enterprise Value of Egetis Therapeutics AB (publ) (EGTX.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Egetis Therapeutics AB (publ) (EGTX.ST) Enterprise Value vs. Peers

How is EGTX.ST’s Enterprise Value compared to its peers?

Egetis Therapeutics AB (publ)’s Enterprise Value is greater than BioInvent International AB (publ) (1.43B), less than Vicore Pharma Holding AB (publ) (1.94B), less than Saniona AB (publ) (2.40B), less than Hansa Biopharma AB (publ) (3.50B), greater than Diamyd Medical AB (publ) (1.06B), greater than Oncopeptides AB (publ) (1.13B), less than Humana AB (publ) (6.53B), greater than SynAct Pharma AB (1.02B), less than Devyser Diagnostics AB (publ) (1.76B), greater than Xspray Pharma AB (publ) (1.14B),

Build a custom stock screener for Egetis Therapeutics AB (publ) (EGTX.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Egetis Therapeutics AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Egetis Therapeutics AB (publ) (EGTX.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Egetis Therapeutics AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.